Item 1A. Risk Factors
2K characters. Original on sec.gov · Markdown
Item 1A. Risk Factors
There have been no material changes from the risk factors previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2024.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Purchases of Equity Securities by the Issuer and Affiliated Purchasers
Our Board has approved the purchase of shares from participants in NXP's equity programs to satisfy participants' tax withholding obligations and this authorization will remain in effect until terminated by the Board. In January 2022, the Board approved the repurchase of shares up to a maximum of $2 billion (the "2022 Share Repurchase Program"). In August 2024, the Board approved the repurchase of shares up to a maximum of $2 billion (the "2024 Share Repurchase Program") in addition to the 2022 Share Repurchase Program. At March 30, 2025, there was approximately $36 million remaining under the 2022 Share Repurchase Program and another $2 billion under the 2024 Share Repurchase Program.
The following share repurchase activity occurred under these programs during the three months ended March 30, 2025:
| Period | Total Number of Shares Purchased | Average Price Paid per Share | Number of Shares Purchased as Part of Publicly Announced Buy Back Programs | Maximum Number of Shares That May Yet Be Purchased Under the Buy Back Program | Number of Shares Purchased as Trade for Tax (1) | ||||||||||||||||||||||||
| January 1, 2025 – February 2, 2025 | 484,186 | $212.26 | 477,700 | 10,716,860 | 6,486 | ||||||||||||||||||||||||
| February 3, 2025 – March 2, 2025 | 466,321 | $221.42 | 460,878 | 9,893,293 | 5,443 | ||||||||||||||||||||||||
| March 3, 2025 – March 30, 2025 | 462,866 | $208.83 | 462,171 | 10,718,353 | 695 | ||||||||||||||||||||||||
| Total | 1,413,373 | 1,400,749 | 12,624 |
(1) Reflects shares surrendered by participants to satisfy tax withholding obligations in connection with the Company's equity programs.
Previous: Item 4. Controls and Procedures · Next: Item 5. Other Information